| Bladder cancer DS Kaufman, WU Shipley, AS Feldman The Lancet 374 (9685), 239-249, 2009 | 1356 | 2009 |
| Long-term oncologic outcomes after radiofrequency ablation for T1 renal cell carcinoma SP Psutka, AS Feldman, WS McDougal, FJ McGovern, P Mueller, ... European urology 63 (3), 486-492, 2013 | 358 | 2013 |
| Long-term outcomes after bladder-preserving tri-modality therapy for patients with muscle-invasive bladder cancer: an updated analysis of the Massachusetts General Hospital … NJ Giacalone, WU Shipley, RH Clayman, A Niemierko, M Drumm, ... European urology 71 (6), 952-960, 2017 | 326 | 2017 |
| Renal cell carcinoma in tuberous sclerosis complex P Yang, KM Cornejo, PM Sadow, L Cheng, M Wang, Y Xiao, Z Jiang, ... The American journal of surgical pathology 38 (7), 895-909, 2014 | 256 | 2014 |
| Adverse effect of paroxetine on sperm C Tanrikut, AS Feldman, M Altemus, DA Paduch, PN Schlegel Fertility and sterility 94 (3), 1021-1026, 2010 | 234 | 2010 |
| Diagnosis and management of dysfunctional voiding AS Feldman, SB Bauer Current opinion in pediatrics 18 (2), 139-147, 2006 | 178 | 2006 |
| Quality of life in long-term survivors of muscle-invasive bladder cancer KS Mak, AB Smith, A Eidelman, R Clayman, A Niemierko, JS Cheng, ... International Journal of Radiation Oncology* Biology* Physics 96 (5), 1028-1036, 2016 | 137 | 2016 |
| Current management of small renal masses, including patient selection, renal tumor biopsy, active surveillance, and thermal ablation A Sanchez, AS Feldman, AA Hakimi Journal of Clinical Oncology 36 (36), 3591, 2018 | 131 | 2018 |
| Sensitive multiplexed analysis of kinase activities and activity-based kinase identification K Kubota, R Anjum, Y Yu, RC Kunz, JN Andersen, M Kraus, H Keilhack, ... Nature biotechnology 27 (10), 933-940, 2009 | 121 | 2009 |
| Renal mass biopsy to guide treatment decisions for small incidental renal tumors: a cost-effectiveness analysis PV Pandharipande, DA Gervais, RI Hartman, MG Harisinghani, ... Radiology 256 (3), 836-846, 2010 | 105 | 2010 |
| Baseline prostate-specific antigen levels in midlife predict lethal prostate cancer MA Preston, JL Batista, KM Wilson, SV Carlsson, T Gerke, DD Sjoberg, ... Journal of Clinical Oncology 34 (23), 2705, 2016 | 101 | 2016 |
| Testicular cancer: what the radiologist needs to know EI Kreydin, GW Barrisford, AS Feldman, MA Preston American Journal of Roentgenology 200 (6), 1215-1225, 2013 | 99 | 2013 |
| Penis transplantation: first US experience CL Cetrulo Jr, K Li, HM Salinas, MD Treiser, I Schol, GW Barrisford, ... Annals of surgery 267 (5), 983-988, 2018 | 98 | 2018 |
| Cystatin B as a tissue and urinary biomarker of bladder cancer recurrence and disease progression AS Feldman, J Banyard, CL Wu, WS McDougal, BR Zetter Clinical cancer research 15 (3), 1024-1031, 2009 | 90 | 2009 |
| Clinical outcomes of patients with histologic variants of urothelial cancer treated with trimodality bladder-sparing therapy RE Krasnow, M Drumm, HJ Roberts, A Niemierko, CL Wu, S Wu, J Zhang, ... European urology 72 (1), 54-60, 2017 | 83 | 2017 |
| Methods for diagnosis and prognosis of epithelial cancers B Zetter, A Feldman, W McDougal US Patent App. 11/829,323, 2008 | 75 | 2008 |
| Primary genitourinary melanoma: epidemiology and disease-specific survival in a large population-based cohort A Sanchez, D Rodríguez, CB Allard, SK Bechis, RJ Sullivan, CE Boeke, ... Urologic Oncology: Seminars and Original Investigations 34 (4), 166. e7-166. e14, 2016 | 74 | 2016 |
| A multigene signature based on cell cycle proliferation improves prediction of mortality within 5 yr of radical nephrectomy for renal cell carcinoma TM Morgan, R Mehra, P Tiemeny, JS Wolf, S Wu, Z Sangale, M Brawer, ... European Urology 73 (5), 763-769, 2018 | 72 | 2018 |
| Long-term outcome of excisional organ sparing surgery for carcinoma of the penis AS Feldman, WS McDougal The Journal of urology 186 (4), 1303-1307, 2011 | 67 | 2011 |
| Radical cystectomy versus trimodality therapy for muscle-invasive bladder cancer: a multi-institutional propensity score matched and weighted analysis AR Zlotta, LK Ballas, A Niemierko, K Lajkosz, C Kuk, G Miranda, ... The Lancet Oncology 24 (6), 669-681, 2023 | 65 | 2023 |
